Bessemer Group’s Praxis Precision Medicines PRAX Stock Holding History

Bessemer Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$41K	Hold	140	–	–	﹤0.01%	1771
2026 Q2	$47K	Buy	+140	New	+$44.3K	﹤0.01%	1718
2025 Q1	–	Sell	-25	Closed	-$1.56K	–	2675
2024 Q4	$2K	Hold	25	–	–	﹤0.01%	2255
2024 Q3	$1K	Buy	+25	New	+$1.35K	﹤0.01%	2506
2022 Q2	–	Sell	-4	Closed	-$1K	–	1998
2022 Q1	$1K	Hold	4	–	–	﹤0.01%	1785
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	1820
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	1632
2021 Q2	$1K	Hold	4	–	–	﹤0.01%	1552
2021 Q1	$2K	Buy	+4	New	+$2.84K	﹤0.01%	1460

Other funds holding PRAX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Bessemer Group's PRAX Position: Q3 2026 in Review

Bessemer Group held its Praxis Precision Medicines (PRAX) position steady in Q3 2026 at 140 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.

Bessemer Group first reported a position in PRAX in Q1 2021 and has held it in 9 quarters since. The position peaked at $47K in Q2 2026. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

Bessemer Group held 140 shares of Praxis Precision Medicines worth $41K as of Q3 2026.
Bessemer Group left its Praxis Precision Medicines share count unchanged in Q3 2026.
Praxis Precision Medicines made up ﹤0.01% of Bessemer Group's portfolio in Q3 2026, its #1771 holding.
Bessemer Group first reported a position in Praxis Precision Medicines in Q1 2021 and has held it in 9 quarters since.
Bessemer Group's Praxis Precision Medicines position peaked at $47K in Q2 2026.
237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.